Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 117

    1.

    Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.

    Illei GG, Yarboro CH, Kuroiwa T, Schlimgen R, Austin HA, Tisdale JF, Chitkara P, Fleisher T, Klippel JH, Balow JE, Boumpas DT.

    Rheumatology (Oxford). 2007 Jun;46(6):952-6. Epub 2007 Feb 22.PMID: 17317716 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set.

    MacLean CH, Saag KG, Solomon DH, Morton SC, Sampsel S, Klippel JH.

    Arthritis Rheum. 2004 Apr 15;51(2):193-202.PMID: 15077259 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.

    Leitman SF, Tisdale JF, Bolan CD, Popovsky MA, Klippel JH, Balow JE, Boumpas DT, Illei GG.

    Transfusion. 2003 Dec;43(12):1667-71.PMID: 14641861 [PubMed - indexed for MEDLINE]Related articles

    4.

    Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

    Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Pando J, Steinberg AD, Gourley MF, Klippel JH, Balow JE, Boumpas DT.

    Arthritis Rheum. 2002 Apr;46(4):995-1002.PMID: 11953977 [PubMed - indexed for MEDLINE]Related articles

    5.

    Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

    Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT.

    Ann Intern Med. 2001 Aug 21;135(4):248-57.PMID: 11511139 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Biologic therapy for rheumatoid arthritis.

    Klippel JH.

    N Engl J Med. 2000 Nov 30;343(22):1640-1. No abstract available. Erratum in: N Engl J Med 2001 Jan 4;344(1):76. PMID: 11096174 [PubMed - indexed for MEDLINE]Related articles

    7.

    Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.

    Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Ménard HA, Zhou ZJ, Palosuo T, Van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR Jr, El-Gabalawy HS.

    Arthritis Res. 2000;2(3):236-43. Epub 2000 Mar 31.PMID: 11056669 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Synovitis occurs in some clinically normal and asymptomatic joints in patients with early arthritis.

    Pando JA, Duray P, Yarboro C, Gourley MF, Klippel JH, Schumacher HR.

    J Rheumatol. 2000 Aug;27(8):1848-54.PMID: 10955323 [PubMed - indexed for MEDLINE]Related articles

    9.

    Update on cyclophosphamide for systemic lupus erythematosus.

    Ortmann RA, Klippel JH.

    Rheum Dis Clin North Am. 2000 May;26(2):363-75, vii. Review.PMID: 10768217 [PubMed - indexed for MEDLINE]Related articles

    10.

    Multicentric reticulohistiocytosis: case report with immunohistochemical analysis and literature review.

    Gorman JD, Danning C, Schumacher HR, Klippel JH, Davis JC Jr.

    Arthritis Rheum. 2000 Apr;43(4):930-8.PMID: 10765941 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Apheresis.

    Illei GG, Klippel JH.

    Rheum Dis Clin North Am. 2000 Feb;26(1):63-73, viii. Review.PMID: 10680194 [PubMed - indexed for MEDLINE]Related articles

    12.

    Association of HLA alleles and clinical features in patients with synovitis of recent onset.

    El-Gabalawy HS, Goldbach-Mansky R, Smith D 2nd, Arayssi T, Bale S, Gulko P, Yarboro C, Wilder RL, Klippel JH, Schumacher HR Jr.

    Arthritis Rheum. 1999 Aug;42(8):1696-705.PMID: 10446870 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Gamma interferon and interleukin-10 gene expression in synovial tissues from patients with early stages of Chlamydia-associated arthritis and undifferentiated oligoarthritis and from healthy volunteers.

    Kotake S, Schumacher HR Jr, Arayssi TK, Gérard HC, Branigan PJ, Hudson AP, Yarboro CH, Klippel JH, Wilder RL.

    Infect Immun. 1999 May;67(5):2682-6.PMID: 10225943 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Why is the ANA result positive?

    Illei GG, Klippel JH.

    Bull Rheum Dis. 1999 Jan;48(1):1-4.PMID: 10028188 [PubMed - indexed for MEDLINE]Related articles

    15.

    Recombinant human Dnase I (rhDNase) in patients with lupus nephritis.

    Davis JC Jr, Manzi S, Yarboro C, Rairie J, Mcinnes I, Averthelyi D, Sinicropi D, Hale VG, Balow J, Austin H, Boumpas DT, Klippel JH.

    Lupus. 1999;8(1):68-76.PMID: 10025601 [PubMed - indexed for MEDLINE]Related articles

    16.

    Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains.

    Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D, Gordon C, Isenberg DA, Klippel JH, Petri M, Simon L, Tugwell P, Wolfe F.

    J Rheumatol. 1999 Feb;26(2):504-7.PMID: 9972996 [PubMed - indexed for MEDLINE]Related articles

    17.

    Indications for, and use of, cytotoxic agents in SLE.

    Klippel JH.

    Baillieres Clin Rheumatol. 1998 Aug;12(3):511-27. Review.PMID: 9890110 [PubMed - indexed for MEDLINE]Related articles

    18.

    Novel approaches in the treatment of lupus nephritis.

    Illei GG, Klippel JH.

    Lupus. 1998;7(9):644-8. Review.PMID: 9884104 [PubMed - indexed for MEDLINE]Related articles

    19.

    High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.

    Davis JC Jr, Fessler BJ, Tassiulas IO, McInnes IB, Yarboro CH, Pillemer S, Wilder R, Fleisher TA, Klippel JH, Boumpas DT.

    J Rheumatol. 1998 Sep;25(9):1694-704.PMID: 9733448 [PubMed - indexed for MEDLINE]Related articles

    20.

    Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patients.

    Tassiulas IO, Aksentijevich I, Salmon JE, Kim Y, Yarboro CH, Vaughan EM, Davis JC, Scott DL, Austin HA, Klippel JH, Balow JE, Gourley MF, Boumpas DT.

    Clin Nephrol. 1998 Jul;50(1):8-13.PMID: 9710341 [PubMed - indexed for MEDLINE]Related articles

    21.

    Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity.

    Langford CA, Klippel JH, Balow JE, James SP, Sneller MC.

    Ann Intern Med. 1998 Jul 1;129(1):49-58. Review.PMID: 9653000 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 1: rheumatologic and renal diseases.

    Langford CA, Klippel JH, Balow JE, James SP, Sneller MC.

    Ann Intern Med. 1998 Jun 15;128(12 Pt 1):1021-8. Review.PMID: 9625665 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis.

    Davis JC Jr, Austin H 3rd, Boumpas D, Fleisher TA, Yarboro C, Larson A, Balow J, Klippel JH, Scott D.

    Arthritis Rheum. 1998 Feb;41(2):335-43. Review.PMID: 9485092 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis.

    Kotake S, Schumacher HR Jr, Yarboro CH, Arayssi TK, Pando JA, Kanik KS, Gourley MF, Klippel JH, Wilder RL.

    Proc Assoc Am Physicians. 1997 May;109(3):286-301.PMID: 9154645 [PubMed - indexed for MEDLINE]Related articles

    25.

    Systemic lupus erythematosus: demographics, prognosis, and outcome.

    Klippel JH.

    J Rheumatol Suppl. 1997 May;48:67-71. Review.PMID: 9150122 [PubMed - indexed for MEDLINE]Related articles

    26.

    Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.

    Gourley MF, Austin HA 3rd, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD.

    Ann Intern Med. 1996 Oct 1;125(7):549-57.PMID: 8815753 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis.

    Yarboro CH, Wesley R, Amantea MA, Klippel JH, Pucino F.

    Ann Pharmacother. 1996 Jul-Aug;30(7-8):752-5.PMID: 8826554 [PubMed - indexed for MEDLINE]Related articles

    28.

    End-stage renal disease and systemic lupus erythematosus.

    Mojcik CF, Klippel JH.

    Am J Med. 1996 Jul;101(1):100-7. Review.PMID: 8686702 [PubMed - indexed for MEDLINE]Related articles

    29.

    Outpatient monthly oral bolus cyclophosphamide therapy in systemic lupus erythematosus.

    Dawisha SM, Yarboro CH, Vaughan EM, Austin HA 3rd, Balow JE, Klippel JH.

    J Rheumatol. 1996 Feb;23(2):273-8.PMID: 8882031 [PubMed - indexed for MEDLINE]Related articles

    30.

    Predicting who will get lupus nephritis.

    Klippel JH.

    J Clin Rheumatol. 1995 Oct;1(5):257-9. No abstract available. PMID: 19077994 [PubMed - in process]Related articles

    31.

    Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis.

    Boumpas DT, Fessler BJ, Austin HA 3rd, Balow JE, Klippel JH, Lockshin MD.

    Ann Intern Med. 1995 Jul 1;123(1):42-53. Review.PMID: 7762914 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease.

    Boumpas DT, Austin HA 3rd, Fessler BJ, Balow JE, Klippel JH, Lockshin MD.

    Ann Intern Med. 1995 Jun 15;122(12):940-50. Review.PMID: 7755231 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Is malignancy a major concern in rheumatoid arthritis patients?

    Cash JM, Klippel JH.

    J Clin Rheumatol. 1995 Feb;1(1):14-22.PMID: 19077936 [PubMed - in process]Related articles

    34.

    Cyclophosphamide: ovarian and other toxicities.

    Klippel JH.

    Lupus. 1995 Feb;4(1):1-2. Review. No abstract available. PMID: 7767331 [PubMed - indexed for MEDLINE]Related articles

    35.

    Curing lupus--views from the foothills.

    Klippel JH.

    Ann Rheum Dis. 1994 Dec;53(12):785-6. No abstract available. PMID: 7864683 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    A pilot study of anti-CD5 ricin A chain immunoconjugate in systemic lupus erythematosus.

    Stafford FJ, Fleisher TA, Lee G, Brown M, Strand V, Austin HA 3rd, Balow JE, Klippel JH.

    J Rheumatol. 1994 Nov;21(11):2068-70.PMID: 7532717 [PubMed - indexed for MEDLINE]Related articles

    37.

    Understanding and using antinuclear antibody testing.

    Pando JA, Klippel JH.

    Contemp Intern Med. 1994 Oct;6(10):71-7.PMID: 10150291 [PubMed - indexed for MEDLINE]Related articles

    38.

    The economic impact of treatment of severe lupus nephritis with prednisone and intravenous cyclophosphamide.

    McInnes PM, Schuttinga J, Sanslone WR, Stark SP, Klippel JH.

    Arthritis Rheum. 1994 Jul;37(7):1000-6.PMID: 8024609 [PubMed - indexed for MEDLINE]Related articles

    39.

    Second-line drug therapy for rheumatoid arthritis.

    Cash JM, Klippel JH.

    N Engl J Med. 1994 May 12;330(19):1368-75. Review. No abstract available. PMID: 8152450 [PubMed - indexed for MEDLINE]Related articles

    40.

    Incidence of cancer among men with the Felty syndrome.

    Gridley G, Klippel JH, Hoover RN, Fraumeni JF Jr.

    Ann Intern Med. 1994 Jan 1;120(1):35-9.PMID: 8250454 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.

    Boumpas DT, Austin HA 3rd, Vaughan EM, Yarboro CH, Klippel JH, Balow JE.

    Ann Intern Med. 1993 Sep 1;119(5):366-9.PMID: 8338289 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Apheresis and the rheumatic diseases.

    Stafford FJ, Klippel JH.

    Bull Rheum Dis. 1993 May;42(3):6-8. Review. No abstract available. PMID: 8334479 [PubMed - indexed for MEDLINE]Related articles

    43.

    Is aggressive therapy effective for lupus?

    Klippel JH.

    Rheum Dis Clin North Am. 1993 Feb;19(1):249-61. Review.PMID: 8356258 [PubMed - indexed for MEDLINE]Related articles

    44.

    Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

    Boumpas DT, Austin HA 3rd, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE.

    Lancet. 1992 Sep 26;340(8822):741-5.PMID: 1356175 [PubMed - indexed for MEDLINE]Related articles

    45.

    Pulse cyclophosphamide for severe neuropsychiatric lupus.

    Boumpas DT, Yamada H, Patronas NJ, Scott D, Klippel JH, Balow JE.

    Q J Med. 1991 Dec;81(296):975-84.PMID: 1808642 [PubMed - indexed for MEDLINE]Related articles

    46.

    Raynaud's phenomenon. The French tricolor.

    Klippel JH.

    Arch Intern Med. 1991 Dec;151(12):2389-93. Review.PMID: 1746995 [PubMed - indexed for MEDLINE]Related articles

    47.

    Rheumatic diseases and cancer.

    Cash JM, Klippel JH.

    Clin Exp Rheumatol. 1991 Mar-Apr;9(2):109-12. No abstract available. PMID: 2060156 [PubMed - indexed for MEDLINE]Related articles

    48.

    Winning the battle, losing the war? Another editorial about rheumatoid arthritis.

    Klippel JH.

    J Rheumatol. 1990 Sep;17(9):1118-22.PMID: 2290151 [PubMed - indexed for MEDLINE]Related articles

    49.

    Immunologic parameters of response in patients with rheumatoid arthritis treated with cyclosporin A.

    Yocum DE, Wilder RL, Dougherty S, Klippel JH, Pillemer S, Wahl S.

    Arthritis Rheum. 1990 Sep;33(9):1310-6.PMID: 2119587 [PubMed - indexed for MEDLINE]Related articles

    50.

    Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus.

    Boumpas DT, Barez S, Klippel JH, Balow JE.

    Ann Intern Med. 1990 May 1;112(9):674-7.PMID: 2334081 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...